GB263T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GB263T, covering 2022-08-05 to 2022-08-05. Get the full timeline:
Most recent: Clinical Trial Update: A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor [Phase 1, Phase 2]